NCT06285201View on ClinicalTrials.gov

Study of Felzartamab in Healthy Adult Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

March 27, 2024

Primary Completion Date

August 15, 2024

Study Completion Date

August 15, 2024

Conditions
Healthy
Interventions
DRUG

T

8 mg/kg IV of Test drug manufactured by I-Mab Biopharma(Hangzhou)

DRUG

R

8 mg/kg IV of Test drug manufactured by Patheon Italia

Trial Locations (1)

Unknown

The First Hospital of Jilin University, Jilin

All Listed Sponsors
lead

TJ Biopharma Co., Ltd.

INDUSTRY

NCT06285201 - Study of Felzartamab in Healthy Adult Subjects | Biotech Hunter | Biotech Hunter